Iterum Therapeutics plc
ITRM
$0.42
$0.000.77%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -37.95% | -33.08% | 25.69% | -8.01% | -21.95% |
| Total Depreciation and Amortization | 1.14% | 0.57% | 33.72% | 3,162.50% | 0.00% |
| Total Amortization of Deferred Charges | -- | -100.00% | 113.84% | -154.94% | 348.51% |
| Total Other Non-Cash Items | 37.39% | 1.54% | -68.20% | 422.67% | -18.05% |
| Change in Net Operating Assets | -479.53% | 35.71% | 81.27% | -1,845.21% | 97.90% |
| Cash from Operations | -56.75% | -55.26% | 28.10% | -59.28% | 60.47% |
| Capital Expenditure | -- | 100.00% | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -80.70% | 35.75% |
| Cash from Investing | -- | 100.00% | -100.18% | -80.70% | 35.81% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | -- | -- | -- |
| Issuance of Common Stock | 6.09% | -19.46% | -54.19% | 155.56% | 3,151.50% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 6.09% | 161.04% | -160.45% | 155.56% | 3,151.50% |
| Foreign Exchange rate Adjustments | -140.00% | 121.74% | -1,050.00% | 92.86% | -55.56% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -642.51% | 103.26% | -207.03% | 27.15% | 449.36% |